Zim Laboratories Ltd - 541400 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), please find enclosed the transcript of Earnings Conference call for Q4 & FY 23 held on Monday, 22nd May, 2023. The same is available on the Website of the Company. Zim Laboratories Ltd - 541400 - Compliances-Reg.24(A)-Annual Secretarial Compliance
In terms of SEBI Circular No. CIR/CFD/CMD1/27/2019 dated February 8, 2019, and Pursuant to Regulation 24A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, please find enclosed herewith an Annual Secretarial Compliance Report for the financial year ended March 31, 2023 issued by Ms. Yuti Nagarkar, Practicing Company Secretary Zim Laboratories Ltd - 541400 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby furnish the details of loss of share certificate received from Link Intime India Private Limited, Registrar and Share Transfer Agent (RTA) of our Company against the request from shareholder for issue of duplicate share certificate and accordingly, RTA has marked stop transfer until Duplicate Share Certificate is issued. Zim Laboratories Ltd - 541400 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), we wish to inform you that the audio recording of Q4 and FY 23 Earnings Conference Call, is available on the Company's website at: https://www.zimlab.in/investor-reports-earnings-call Zim Laboratories Ltd - 541400 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copies of Newspaper Publication regarding Financial Results for the quarter and year ended as on 31.03.2023, published on 20.05.2023 in the following newspapers :- 1) Financial Express (English) 2) Indian Express (English) 3) Economic Times (English) 4) Loksatta (Marathi) Kindly take the intimation on record. Zim Laboratories Ltd - 541400 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dear Sir, Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby furnish the details of loss of share certificate received from Link Intime India Private Limited, Registrar and Share Transfer Agent (RTA) of our Company against the request from shareholder for issue of duplicate share certificate and accordingly, RTA has marked stop transfer until Duplicate Share Certificate is issued. Zim Laboratories Ltd - 541400 - Announcement under Regulation 30 (LODR)-Investor Presentation
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, kindly find enclosed Investor Presentation May 2023. Zim Laboratories Ltd - 541400 - Disclosure Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
In compliance with Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the disclosure of Related Party Transactions for the half year ended 31st March, 2023 is enclosed. Zim Laboratories Ltd - 541400 - Financial Results For March 31, 2023
In terms of Regulation 30 of SEBI (Listing Obligations Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today has inter-alia considered and approved: 1) the Audited Financial Statements (Standalone and Consolidated) of the Company for the year ended 31st March, 2023. 2) the Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended 31st March, 2023 (prepared pursuant to SEBI (LODR) Regulations, 2015). Walker Chandiok & Co LLP, Chartered Accountants, the Statutory Auditors of the Company have issued auditor''s report with an unmodified opinion on the financial results for the year ended 31.03.2023. Zim Laboratories Ltd - 541400 - Board Meeting Outcome for Outcome Of Board Meeting Held On 19.05.2023
In terms of Regulation 30 of SEBI (Listing Obligations Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today has inter-alia considered and approved: 1) the Audited Financial Statements (Standalone and Consolidated) of the Company for the year ended 31st March, 2023. 2) the Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended 31st March, 2023 (prepared pursuant to SEBI (LODR) Regulations, 2015). Walker Chandiok & Co LLP, Chartered Accountants, the Statutory Auditors of the Company have issued auditor''s report with an unmodified opinion on the financial results for the year ended 31.03.2023.